Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
The once-daily oral therapy is administered as a 14-day course. Clinical trials ...
Approval enables access to targeted therapy for adults and adolescents aged 12 ...
Manjiri Gharat,FIP India Envoy; VP,SEARPharm Forum of FIP; I/C Principal,K.M.Ku...
Biocon Group Chairperson recognised in Mumbai ceremony for contributions to gl...
Formycon to develop and supply Pembrolizumab biosimilar FYB206, while Zydus Lif...
Researchers say comparing unknown compounds in a patient’s blood or urine to tho...
Het bericht Violence against women and children emerges as major global health c...
A brain–computer interface (BCI), called the Biological Interface System to Cort...
DATA FROM A NEW survey show that U.S. health care organizations are increasing t...
NeurIPS hosted over 24,000 machine learning researchers in San Diego, among whic...
In preclinical studies, D16-M1P2 showed consistent potency in CCNE1-amplified br...
In a Phase III clinical trial, over half of patients who received a limited cour...
HN Summary • UHN surgeons are curing a rare and potentially fatal lung condition...
Brelovitug in Phase II trials demonstrated strong antiviral activity in Hepatiti...
Het bericht Hologic expands Genius digital pathology system with CE marking vers...
Het bericht Philips launches helium-free 3T MRI platform verscheen eerst op Inte...
